Stock A314130 GENOME & COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Genome & Company

Equities

A314130

KR7314130006

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 19/06/2024 am IST 		5-day change 1st Jan Change
8,290 KRW -2.47% Intraday chart for Genome & Company -16.26% -33.63%
24/01 Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio®? for the Treatment of Gastric Cancer Poster Presented at ASCO GI CI
2023 Genome & Company Announces Positive Results from Interim Analysis of Gen-001 Plus Avelumab (Bavencio®?) Phase II Trial CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GENOME & COMPANY
Other Biotechnology & Medical Research
-2.47%-16.26%-33.63%-54.80%-82.32% 9.37Cr - - -
  1. Stock Market
  2. Equities
  3. A314130 Stock
  4. Charts Genome & Company
  5. Relative Strength Chart